NEXTBio Capital Management LP 13F Holdings · Q2 2026
NEXTBio Capital Management LP reported 22 securities worth $217.40M in its SEC 13F filing for Q2 2026 (period ended 2026-06-30). Top holdings: PTGX (12.37%), STTK (11.90%), CMPS (11.56%). Among its top 25 positions this quarter: 3 new, 7 added, 5 trimmed, 3 exited.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | PTGX | PROTAGONIST THERAPEUTICS INC | $26.9M | 12.37% | 219,333 | Trimmed |
| 2 | STTK | SHATTUCK LABS INC | $25.9M | 11.90% | 3.7M | Added |
| 3 | CMPS | COMPASS PATHWAYS PLC | $25.1M | 11.56% | 1.8M | Trimmed |
| 4 | GPCR | STRUCTURE THERAPEUTICS INC | $16.8M | 7.71% | 312,496 | Added |
| 5 | VOR | VOR BIOPHARMA INC | $16.4M | 7.53% | 889,164 | Trimmed |
| 6 | RYTM | RHYTHM PHARMACEUTICALS INC | $14.6M | 6.73% | 131,758 | Added |
| 7 | PVLA | PALVELLA THERAPEUTICS INC NE | $13.7M | 6.32% | 89,909 | Added |
| 8 | XENE | XENON PHARMACEUTICALS INC | $11.1M | 5.09% | 183,225 | Hold |
| 9 | ZBIO | ZENAS BIOPHARMA INC | $10.8M | 4.98% | 426,736 | Hold |
| 10 | ORIC | ORIC PHARMACEUTICALS INC | $7.6M | 3.52% | 706,124 | Added |
| 11 | IVA | INVENTIVA SA | $6.8M | 3.11% | 1.8M | Added |
| 12 | CBIO | CRESCENT BIOPHARMA INC. | $6.7M | 3.09% | 372,856 | Hold |
| 13 | PCVX | VAXCYTE INC | $6.2M | 2.87% | 107,223 | Added |
| 14 | COGT | COGENT BIOSCIENCES INC | $5.1M | 2.33% | 131,075 | Trimmed |
| 15 | VSTM | VERASTEM INC | $5.0M | 2.30% | 1.3M | Hold |
| 16 | IRON | DISC MEDICINE INC | $3.9M | 1.77% | 52,655 | Hold |
| 17 | PHVS | PHARVARIS N V | $3.7M | 1.72% | 108,055 | New |
| 18 | ZLAB | ZAI LAB LTD | $3.5M | 1.60% | 183,362 | Hold |
| 19 | BIOA | BIOAGE LABS INC | $2.5M | 1.14% | 100,732 | New |
| 20 | LBRX | LB PHARMACEUTICALS INC | $2.2M | 1.02% | 68,249 | New |
| 21 | EVMN | EVOMMUNE INC | $1.6M | 0.73% | 119,063 | Trimmed |
| 22 | ACET | ADICET BIO INC | $1.4M | 0.63% | 157,827 | Hold |
| 23 | CMPX | COMPASS THERAPEUTICS INC | $0 | 0.00% | 0 | Exited |
| 24 | KALV | KALVISTA PHARMACEUTICALS INC | $0 | 0.00% | 0 | Exited |
| 25 | OCS | OCULIS HOLDING AG | $0 | 0.00% | 0 | Exited |
Source: SEC Form 13F filings · as of 2026-06-30
Every position in this 13F-HR, with its change from the prior quarter.
13F holdings, latest quarter
SourceSEC EDGAR13F-HR